Abbott India Limited Total Liabilities
Abbott India Limited total liabilities. Based on the latest financial reports, Abbott India Limited (ABBOTINDIA) has total liabilities worth Rs16.84 Billion INR (≈ $182.07 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check ABBOTINDIA asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Abbott India Limited (2005–2025)
Total liabilities of Abbott India Limited from 2005 to 2025. This chart illustrates how Abbott India Limited's total liabilities have evolved over time, based on quarterly financial data. Explore Abbott India Limited (ABBOTINDIA) investment intensity to see how much of total assets are deployed in long-term investments.
Abbott India Limited Competitors by Total Liabilities
The table below lists competitors of Abbott India Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
TXNM Energy, Inc.
NYSE:TXNM
|
USA | $8.89 Billion |
|
Amdocs Limited
F:AOS
|
Germany | €2.88 Billion |
|
Rayonier Inc
NYSE:RYN
|
USA | $1.20 Billion |
|
Essential Properties Realty Trust Inc
NYSE:EPRT
|
USA | $2.76 Billion |
|
Sam Yang Foods
KO:003230
|
Korea | ₩1.20 Trillion |
|
Reinet Investments S.C.A
AS:REINA
|
Netherlands | €2.00 Million |
|
News Corp B
NASDAQ:NWS
|
USA | $6.05 Billion |
|
Amneal Pharmaceuticals, Inc. Class A Common Stock
NASDAQ:AMRX
|
USA | $3.66 Billion |
Liability Composition Analysis (2005–2025)
This chart breaks down Abbott India Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Abbott India Limited (ABBOTINDIA) total assets.
Liquidity & Leverage Metrics
Abbott India Limited Total Liabilities Ratios Explained
Abbott India Limited total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.75 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.90 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.42 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Abbott India Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Abbott India Limited (2005–2025)
The table below shows the annual total liabilities of Abbott India Limited from 2005 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | Rs16.84 Billion ≈ $182.14 Million |
+12.68% |
| 2024-03-31 | Rs14.95 Billion ≈ $161.64 Million |
+9.34% |
| 2023-03-31 | Rs13.67 Billion ≈ $147.83 Million |
-2.66% |
| 2022-03-31 | Rs14.04 Billion ≈ $151.87 Million |
+13.41% |
| 2021-03-31 | Rs12.38 Billion ≈ $133.92 Million |
+11.04% |
| 2020-03-31 | Rs11.15 Billion ≈ $120.60 Million |
+19.61% |
| 2019-03-31 | Rs9.32 Billion ≈ $100.83 Million |
+28.88% |
| 2018-03-31 | Rs7.23 Billion ≈ $78.24 Million |
+6.57% |
| 2017-03-31 | Rs6.79 Billion ≈ $73.42 Million |
+61.28% |
| 2016-03-31 | Rs4.21 Billion ≈ $45.52 Million |
-3.48% |
| 2015-03-31 | Rs4.36 Billion ≈ $47.16 Million |
+42.46% |
| 2014-03-31 | Rs3.06 Billion ≈ $33.11 Million |
+17.63% |
| 2013-03-31 | Rs2.60 Billion ≈ $28.15 Million |
+1.62% |
| 2012-03-31 | Rs2.56 Billion ≈ $27.70 Million |
+68.54% |
| 2011-03-31 | Rs1.52 Billion ≈ $16.43 Million |
+30.41% |
| 2010-03-31 | Rs1.17 Billion ≈ $12.60 Million |
-9.89% |
| 2009-03-31 | Rs1.29 Billion ≈ $13.98 Million |
+30.15% |
| 2008-03-31 | Rs993.60 Million ≈ $10.75 Million |
+4.93% |
| 2007-03-31 | Rs946.90 Million ≈ $10.24 Million |
+0.81% |
| 2006-03-31 | Rs939.30 Million ≈ $10.16 Million |
-24.15% |
| 2005-03-31 | Rs1.24 Billion ≈ $13.39 Million |
-- |
About Abbott India Limited
Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It also provides anti-infectives, cardio-diabeto, GI & hepato, hormones, … Read more